Valeant Pharmaceuticals Intl (NYSE:VRX) saw a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 4,969,534 shares, a growth of 57.7% from the August 14th total of 3,151,370 shares, MarketBeat reports. Approximately 1.5% of the company’s shares are short sold. Based on an average daily […]
